BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36448679)

  • 1. Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia.
    Jurado R; Huguet M; Xicoy B; Cabezon M; Jimenez-Ponce A; Quintela D; De La Fuente C; Raya M; Vinets E; Junca J; Julià-Torras J; Zamora L; Oriol A; Navarro JT; Calvo X; Sorigue M
    Cytometry B Clin Cytom; 2023 Jul; 104(4):319-330. PubMed ID: 36448679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis.
    Hwang SM; Ahn H; Jeon S; Park J; Chang Y; Kim H
    J Clin Lab Anal; 2021 Jan; 35(1):e23576. PubMed ID: 32931067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening.
    Vazquez R; Roussel M; Badaoui B; Freynet N; Tarfi S; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
    Cytometry B Clin Cytom; 2018 Sep; 94(5):658-661. PubMed ID: 29108126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.
    Hudson CA; Burack WR; Leary PC; Bennett JM
    Am J Clin Pathol; 2018 Aug; 150(4):293-302. PubMed ID: 29982327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study.
    Zawada AM; Fell LH; Untersteller K; Seiler S; Rogacev KS; Fliser D; Ziegler-Heitbrock L; Heine GH
    Cytometry A; 2015 Aug; 87(8):750-8. PubMed ID: 26062127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real world implementation of flow cytometric monocyte subset partitioning for distinguishing chronic myelomonocytic leukaemia from other causes of monocytosis.
    Barge L; Gooch M; Hendle M; Simleit E
    Pathology; 2023 Oct; 55(6):827-834. PubMed ID: 37541805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
    Selimoglu-Buet D; Wagner-Ballon O; Saada V; Bardet V; Itzykson R; Bencheikh L; Morabito M; Met E; Debord C; Benayoun E; Nloga AM; Fenaux P; Braun T; Willekens C; Quesnel B; Adès L; Fontenay M; Rameau P; Droin N; Koscielny S; Solary E;
    Blood; 2015 Jun; 125(23):3618-26. PubMed ID: 25852055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.
    Picot T; Aanei CM; Flandrin Gresta P; Noyel P; Tondeur S; Tavernier Tardy E; Guyotat D; Campos Catafal L
    Front Oncol; 2018; 8():109. PubMed ID: 29707521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
    Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
    Front Immunol; 2019; 10():1761. PubMed ID: 31402918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets.
    Tallone T; Turconi G; Soldati G; Pedrazzini G; Moccetti T; Vassalli G
    J Cardiovasc Transl Res; 2011 Apr; 4(2):211-9. PubMed ID: 21308491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
    Solary E; Wagner-Ballon O; Selimoglu-Buet D
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101134. PubMed ID: 32460985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis.
    Tarfi S; Harrivel V; Dumezy F; Guy J; Roussel M; Mimoun A; Fenaux P; Chapuis N; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
    Blood Cancer J; 2018 Nov; 8(11):114. PubMed ID: 30429467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14/16 monocyte profiling in juvenile myelomonocytic leukemia.
    Gadgeel M; Bagla S; Buck S; Shamoun M; Ravindranath Y
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28555. PubMed ID: 32648963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
    Wagner-Ballon O; Bettelheim P; Lauf J; Bellos F; Della Porta M; Travaglino E; Subira D; Lopez IN; Tarfi S; Westers TM; Johansson U; Psarra K; Karathanos S; Matarraz S; Colado E; Gupta M; Ireland R; Kern W; Van De Loosdrecht AA;
    Cytometry B Clin Cytom; 2023 Jan; 104(1):66-76. PubMed ID: 34967500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood.
    Rundgren IM; Bruserud Ø; Ryningen A; Ersvær E
    J Immunol Methods; 2018 Oct; 461():53-62. PubMed ID: 29906454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.